Krishna Institute of Medical Sciences Limited (KIMS) has informed BSE and NSE that its promoter and promoter group did not create any fresh encumbrance on their shareholding during the financial year ended March 31, 2026. The declaration was submitted under Regulation 31(4) read with Regulation 31(5) of the SEBI Takeover Regulations. KIMS is traded on BSE under scrip code 543308 and on NSE under the symbol KIMS.
Dr. Bhaskara Rao Bollineni, Chairman and Managing Director of KIMS, made the disclosure on behalf of the promoter and promoter group. The filing confirms that no shares were pledged, directly or indirectly, during FY26 beyond those already reported to the exchanges.
The promoter and promoter group collectively hold 3,64,89,330 equity shares, representing 34.11 percent of KIMS's total paid-up capital. Dr. Bhaskara Rao Bollineni individually holds 1,50,99,645 shares, equivalent to 26.27 percent of the company's equity.
The sole existing encumbrance among the promoter group is on Dr. Bhaskara Rao Bollineni's holding, with 1,40,00,000 shares under pledge. This pledged stake accounts for 3.50 percent of KIMS's total paid-up equity. No other promoter group member has any shares under pledge.
Other promoter group shareholders include Raiyasri Bollineni with 68,70,015 shares, Bluebridee Capital Private Limited holding 2,42,03,310 shares, Abhinay Bollineni with 2,36,495 shares, Adwik Bollineni with 40,640 shares, and Sweata Raavi holding 39,225 shares.
The promoter group's aggregate pledged position of 1,40,00,000 shares represents 38.4 percent of their total holding of 3,64,89,330 equity shares in KIMS.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.